Susquehanna International Group, LLP Takeda Pharmaceutical CO LTD Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	SELL	$13.89 - $15.04 $866,736 - $938,496	-62,400 Reduced 66.74%	31,100 $431,000
Q4 2023 Feb 14, 2024	SELL	$13.36 - $15.43 $12,024 - $13,887	-900 Reduced 0.95%	93,500 $1.33 Million
Q3 2023 Nov 14, 2023	SELL	$15.03 - $16.32 $2.2 Million - $2.39 Million	-146,700 Reduced 60.85%	94,400 $1.46 Million
Q2 2023 Aug 11, 2023	BUY	$15.57 - $17.11 $3.07 Million - $3.38 Million	197,300 Added 450.46%	241,100 $3.79 Million
Q1 2023 May 16, 2023	SELL	$15.28 - $16.48 $15.6 Million - $16.8 Million	-1,019,100 Reduced 95.88%	43,800 $721,000
Q4 2022 Feb 14, 2023	BUY	$12.42 - $15.62 $11.5 Million - $14.5 Million	927,200 Added 683.27%	1,062,900 $16.6 Million
Q3 2022 Nov 14, 2022	SELL	$12.8 - $28.65 $16 Million - $35.9 Million	-1,252,100 Reduced 90.22%	135,700 $1.76 Million
Q2 2022 Aug 15, 2022	BUY	$13.12 - $15.03 $805,568 - $922,842	61,400 Added 4.63%	1,387,800 $19.5 Million
Q1 2022 May 16, 2022	BUY	$13.54 - $15.35 $9.15 Million - $10.4 Million	676,000 Added 103.94%	1,326,400 $19 Million
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $994,335 - $1.24 Million	75,500 Added 13.13%	650,400 $8.87 Million
Q3 2021 Nov 15, 2021	SELL	$16.3 - $17.26 $352,080 - $372,816	-21,600 Reduced 3.62%	574,900 $9.42 Million
Q2 2021 Aug 11, 2021	SELL	$16.55 - $18.64 $2.39 Million - $2.69 Million	-144,400 Reduced 19.49%	596,500 $10 Million
Q1 2021 May 17, 2021	SELL	$16.71 - $19.9 $2.38 Million - $2.84 Million	-142,500 Reduced 16.13%	740,900 $13.5 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $18.97 $7.51 Million - $9.26 Million	488,200 Added 123.53%	883,400 $16.1 Million
Q3 2020 Nov 16, 2020	BUY	$17.1 - $19.19 $391,590 - $439,451	22,900 Added 6.15%	395,200 $7.05 Million
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $510,650 - $682,500	-35,000 Reduced 8.59%	372,300 $6.68 Million
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $4.57 Million - $7.13 Million	-350,900 Reduced 46.28%	407,300 $6.18 Million
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $236,320 - $291,620	14,000 Added 1.88%	758,200 $15 Million
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $1.16 Million - $1.3 Million	-72,100 Reduced 8.83%	744,200 $12.8 Million
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $1.7 Million - $2.1 Million	102,500 Added 14.36%	816,300 $14.4 Million
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $9.44 Million - $12.2 Million	565,200 Added 380.35%	713,800 $14.5 Million
Q4 2018 Feb 14, 2019	BUY	$15.64 - $21.1 $2.32 Million - $3.14 Million	148,600 New	148,600 $2.5 Million

Others Institutions Holding TAK

# of Institutions

320

Shares Held

70.4M

Call Options Held

939K

Put Options Held

233K

Capital Research Global Investors Los Angeles, CA

13.1M
Shares

$182 Million
0.04% of portfolio
Mondrian Investment Partners LTD London, X0

7.74M
Shares

$107 Million
1.74% of portfolio
Morgan Stanley New York, NY

4.99M
Shares

$69.1 Million
0.01% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.35M
Shares

$60.2 Million
0.03% of portfolio
Goldman Sachs Group Inc New York, NY

3.72M
Shares

$51.5 Million
0.01% of portfolio

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account